Indian Immunologicals denies Australian warning on Abhayrab rabies vaccine, citing one outdated batch issue and global safety record.

Indian Immunologicals Ltd says an Australian advisory warning about counterfeit Abhayrab rabies vaccine batches since 2023 is outdated and misleading. The company confirmed only one batch (KA 24014) had a packaging anomaly in January 2025, which was promptly reported to Indian regulators and removed from circulation. All IIL vaccines undergo mandatory testing by India’s Central Drugs Laboratory, and the company insists authorized government and distributor channels continue to provide safe, effective vaccines. Over 210 million doses have been distributed globally since 2000, with Abhayrab holding a 40% market share in India.